Results 181 to 190 of about 49,657 (223)

Characterization of Nucleoside Reverse Transcriptase Inhibitor-Associated Mutations in the RNase H Region of HIV-1 Subtype C Infected Individuals. [PDF]

Viruses, 2017
Ngcapu S, Theys K, Libin P, Marconi VC, Sunpath H, Ndung'u T, Gordon ML.   +6 more
europepmc   +1 more source

Mechanistic Study of Common Non-Nucleoside Reverse Transcriptase Inhibitor-Resistant Mutations with K103N and Y181C Substitutions. [PDF]

Viruses, 2016
Lai MT, Munshi V, Lu M, Feng M, Hrin-Solt R, McKenna PM, Hazuda DJ, Miller MD.   +7 more
europepmc   +1 more source

Superior Efficacy of Dolutegravir (DTG) Plus 2 Nucleoside Reverse Transcriptase Inhibitors (NRTIs) Compared with lopinavir/ritonavir (LPV/r) Plus 2 NRTIs in Second-Line Treatment — 48-week Data from the DAWNING Study

, 2019
Michael Aboud, Richard Kaplan, Johannes Lombaard, F. Zhang, José A. Hidalgo, Elmira Mamedova, Marcelo Losso, Ploenchan Chetchotisakd, Carlos Brites, Jörg Sievers, Dannae Brown, Judy Hopking, Mark Underwood, M. C. Nascimento, Martin Gartland, K. Smith, C. R. Steinhart, José M. Gatell   +17 more
openalex   +1 more source

Structure-Based Design, Synthesis, and Biological Evaluation of Conformationally Restricted Novel 2-Alkylthio-6-[1-(2,6-difluorophenyl)alkyl]- 3,4-dihydro-5-alkylpyrimidin-4(3H)-ones as Non-nucleoside Inhibitors of HIV-1 Reverse Transcriptase

, 2001
Antonello Mai, Gianluca Sbardella, Marino Artico, Rino Ragno, Silvio Massa, Ettore Novellino, Giovanni Greco, Antonio Lavecchia, Chiara Musiu, Massimiliano La Colla, Chiara Murgioni, Paolo La Colla, Roberta Loddo   +12 more
openalex   +1 more source

Non-Nucleoside Reverse Transcriptase Inhibitor-Based Antiretroviral Therapy in Perinatally HIV-Infected, Treatment-Naïve Adolescents in Asia. [PDF]

J Adolesc Health, 2016
Boettiger DC, Sudjaritruk T, Nallusamy R, Lumbiganon P, Rungmaitree S, Hansudewechakul R, Kumarasamy N, Bunupuradah T, Saphonn V, Truong KH, Yusoff NKN, Do VC, Nguyen LV, Razali KAM, Fong SM, Kurniati N, Kariminia A.   +16 more
europepmc   +1 more source

Insights into the Molecular Mechanism of Polymerization and Nucleoside Reverse Transcriptase Inhibitor Incorporation by Human PrimPol. [PDF]

Antimicrob Agents Chemother, 2016
Mislak AC, Anderson KS.
europepmc   +1 more source

The Human Immunodeficiency Virus Type 1 Nonnucleoside Reverse Transcriptase Inhibitor Resistance Mutation I132M Confers Hypersensitivity to Nucleoside Analogs

, 2009
Zandrea Ambrose, Brian D. Herman, Chih‐Wei Sheen, Shannon Zelina, Katie L. Moore, Gilda Tachedjian, Dwight V. Nissley, Nicolas Sluis‐Cremer   +7 more
openalex   +2 more sources

Identification of a dibenzocyclooctadiene lignan as a HIV-1 non-nucleoside reverse transcriptase inhibitor. [PDF]

Antivir Chem Chemother, 2015
Han YS, Xiao WL, Xu H, Kramer VG, Quan Y, Mesplède T, Oliveira M, Colby-Germinario SP, Sun HD, Wainberg MA.   +9 more
europepmc   +1 more source

HIV CRF08_BC AND X4 STRAIN ARE ASSOCIATED WITH POSING MAJOR NUCLEOSIDE AND NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS RESISTANCE MUTATIONS

, 2015
Afiono Agung Prasetyo, Ratna Sariyatun
openalex   +1 more source

Parallel one-pot synthesis and structure–activity relationship study of symmetric formimidoester disulfides as a novel class of potent non-nucleoside HIV-1 reverse transcriptase inhibitors

, 2008
Sara Cesarini, Andrea Spallarossa, Angelo Ranise, Silvia Schenone, Olga Bruno, Paolo La Colla, Laura Casula, Gabriella Collu, Giuseppina Sanna, Roberta Loddo   +9 more
openalex   +1 more source